BDBM278483 (2S)-2-(dimethylamino)-2-(o-tolyl)-N-[5-[[(3R)-::US10040789, Example 17
SMILES: CN(C)[C@H](C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2cccnn2)s1)c1ccccc1C
InChI Key: InChIKey=QKVJMGFCCLINQD-QAPCUYQASA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glutaminase kidney isoform, mitochondrial (Homo sapiens (Human)) | BDBM278483 ((2S)-2-(dimethylamino)-2-(o-tolyl)-N-[5-[[(3R)- | ...) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 187 | n/a | n/a | n/a | n/a | 7.8 | 25 |
AstraZeneca AB; Cancer Research Technology Limited US Patent | Assay Description A Glutamate Oxidase/AmplexRed coupled assay was used to measure the ability of compounds to bind to and inhibit the activity of GLS1 in vitro. 6His t... | US Patent US10040789 (2018) BindingDB Entry DOI: 10.7270/Q2TB18X9 | |||||||||||
More data for this Ligand-Target Pair |